Literature DB >> 1840663

Comparative sequence analysis of defective and infectious avian hepadnaviruses.

R Sprengel1, R Schneider, P L Marion, D Fernholz, G Wildner, H Will.   

Abstract

Mesh：

Year:  1991        PMID： 1840663      PMCID： PMC328575          DOI： 10.1093/nar/19.15.4289

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  6 in total

1.  Complete nucleotide sequence of a German duck hepatitis B virus.

Authors:  F Mattes; S Tong; K Teubner; H E Blum
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

2.  Complete nucleotide sequence of a Chinese duck hepatitis B virus.

Authors:  S Tong; F Mattes; K Teubner; H E Blum
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

3.  Molecular cloning and sequence analysis of duck hepatitis B virus genomes of a new variant isolated from Shanghai ducks.

Authors:  M Uchida; M Esumi; T Shikata
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

4.  Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences.

Authors:  E Mandart; A Kay; F Galibert
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  Isolation and characterization of a hepatitis B virus endemic in herons.

Authors:  R Sprengel; E F Kaleta; H Will
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Comparative sequence analysis of duck and human hepatitis B virus genomes.

Authors:  R Sprengel; C Kuhn; H Will; H Schaller
Journal:  J Med Virol       Date:  1985-04       Impact factor: 2.327
  6 in total
  9 in total

1.  Avian hepatitis B virus infection is initiated by the interaction of a distinct pre-S subdomain with the cellular receptor gp180.

Authors:  S Urban; K M Breiner; F Fehler; U Klingmüller; H Schaller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

2.  Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame.

Authors:  S F Chang; H J Netter; E Hildt; R Schuster; S Schaefer; Y C Hsu; A Rang; H Will
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Enhancement of hepatitis B virus infection by noninfectious subviral particles.

Authors:  M Bruns; S Miska; S Chassot; H Will
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Molecular characterization of duck hepatitis B virus isolates from South African ducks.

Authors:  Nomathibane P Mangisa; Heidi E Smuts; Anna Kramvis; C Wendy Linley; Michelle Skelton; Timothy J Tucker; Pauline De La M Hall; Del Kahn; Allison R Jilbert; Michael C Kew
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

5.  Monoclonal antibodies providing topological information on the duck hepatitis B virus core protein and avihepadnaviral nucleocapsid structure.

Authors:  Jolanta Vorreiter; Immanuel Leifer; Christine Rösler; Ludmila Jackevica; Paul Pumpens; Michael Nassal
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

6.  Naturally occurring point mutation in the C terminus of the polymerase gene prevents duck hepatitis B virus RNA packaging.

Authors:  Y Chen; W S Robinson; P L Marion
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  New hepatitis B virus of cranes that has an unexpected broad host range.

Authors:  Alexej Prassolov; Heinz Hohenberg; Tatyana Kalinina; Carola Schneider; Lucyna Cova; Oliver Krone; Kai Frölich; Hans Will; Hüseyin Sirma
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes.

Authors:  J E Newbold; H Xin; M Tencza; G Sherman; J Dean; S Bowden; S Locarnini
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Pre-P is a secreted glycoprotein encoded as an N-terminal extension of the duck hepatitis B virus polymerase gene.

Authors:  Feng Cao; Catherine A Scougall; Allison R Jilbert; John E Tavis
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.